PLRX Pliant Therapeutics, Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
22:22
Aug 18
Aug 18
Author confirms holding Cytokinetics since 2024 and added at $82.80.
Author confirms holding Cytokinetics since 2024 and added at $82.80, while listing other long ideas and short candidates from a prior post without explicit current positioning.
About PLRX Analyst Coverage
Buzzberg tracks PLRX (Pliant Therapeutics, Inc.) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Latest voices: seedy19tron.